Page last updated: 2024-10-25

cimetidine and Lupus Erythematosus, Cutaneous

cimetidine has been researched along with Lupus Erythematosus, Cutaneous in 1 studies

Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.

Lupus Erythematosus, Cutaneous: A form of lupus erythematosus in which the skin may be the only organ involved or in which skin involvement precedes the spread into other body systems. It has been classified into three forms - acute (= LUPUS ERYTHEMATOSUS, SYSTEMIC with skin lesions), subacute, and chronic (= LUPUS ERYTHEMATOSUS, DISCOID).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Marzano, AV1
Capsoni, F1
Berti, E1
Gasparini, G1
Bottelli, S1
Caputo, R1

Other Studies

1 other study available for cimetidine and Lupus Erythematosus, Cutaneous

ArticleYear
Amicrobial pustular dermatosis of cutaneous folds associated with autoimmune disorders: a new entity?
    Dermatology (Basel, Switzerland), 1996, Volume: 193, Issue:2

    Topics: Adult; Ascorbic Acid; Autoantibodies; Autoimmune Diseases; Celiac Disease; Chemotaxis, Leukocyte; Ci

1996